Seek truth from facts, competitive symbiosis
Zhengqing Pharmaceutical Group's equity confirmation work is nearing its end.
Category:
Release time:
2014-08-18
Our newspaper learned (Correspondent Luo Ping) that currently, the equity confirmation work of Hunan Zhengqing Pharmaceutical Group Co., Ltd. has entered its final stage. From May to July, Zhengqing Pharmaceutical Group successively published the "Announcement on Shareholder Information Verification and On-site Confirmation of Hunan Zhengqing Pharmaceutical Group Co., Ltd." in "Hunan Daily" and "Huaihua Daily", and held multiple equity confirmation sessions in Huaihua, Changsha, and Hengyang.
The equity confirmation work holds significant importance for Zhengqing Pharmaceutical Company and its shareholders. Zhengqing Pharmaceutical Company is a long-established unlisted public company founded in 1994, an influential pharmaceutical company in the Huaihua region and Hunan Province. The company's shares were traded over-the-counter in the year it was founded, and some internal employee shares were converted into public shares. The company has a large number of shareholders, approximately 2200 people. The company's IPO listing has always been an expectation of its shareholders, but due to policy reasons, the number of shareholders exceeding 200 became an obstacle to the company's IPO listing, and Zhengqing Pharmaceutical Group's IPO listing had once faltered.
In December last year, the China Securities Regulatory Commission (CSRC) introduced new policies, launching review guidelines for unlisted joint-stock companies with over 200 shareholders for listing on the "New Third Board" and for IPO listing. The prerequisites were that the shareholder share confirmation rates must reach 80% and 90% respectively. It was against this backdrop that Zhengqing Pharmaceutical Group, in conjunction with Hunan Equity Registration Center and a third-party law firm, initiated the equity confirmation work. It is understood that after the launch of the equity confirmation work, Zhengqing Pharmaceutical Group shareholders spread the word and actively participated in the equity confirmation. As of July 30th, Zhengqing Pharmaceutical Group has completed all announcement tasks, with approximately 1100 shareholders having confirmed their rights, and the share confirmation rate reaching 82.9%.
Due to the large number of Zhengqing Pharmaceutical Group shareholders in the Huaihua region, half of the shareholders have not yet confirmed their rights for various reasons. Considering the needs of these shareholders, the company has decided to add an equity confirmation session at its Changsha headquarters (Zhengqing Pharmaceutical, 4th Floor, Block A, Building 1, International Enterprise Center, No. 188 Huanbao Middle Road, Yuhua District, Changsha City, Hunan Province) on August 29th from 9:00 to 16:00. For more information, please follow the WeChat official account (HNZQZY99)
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地